SNCA and supranuclear palsy, progressive, 1: A cross-sectional study reported higher pS129 in PD patients compared to healthy controls or MSA or PSP; the ratio of pS129/total α-synuclein is significantly higher in PD than in healthy controls or PSP (Wang Y. et al., 2012).